Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Viewpoints

Jul 1, 2017/Magazine

An SLP in a PT world

Arc Sign

Nov 30, 2017/Test & Measure

This can be used on anyone with suspected Achilles tendinopathy.

Defining Moment: A Difficult Question

Jun 1, 2023/Column

In honor of Father's Day this month, one PT recollects the hardest thing his father ever asked him.

Potential Big Prior Authorization Win: CMS Proposes Significant Changes

Dec 14, 2022/News

The APTA-supported rule increases transparency and lowers admin burden across a range of programs including Medicaid and Medicare Advantage.

Securing Legal Counsel & Finding an Attorney

Sep 1, 2019/Article

For assistance with legal matters, PTs and PTAs should seek advice of legal counsel who can review their unique situation and provide advice tailored to the specific facts.

Payment Advocacy Takes Center Stage During APTA Capitol Hill Day

May 5, 2026/Article

APTA members gather in front of the U.S. Capitol during APTA Capitol Hill Day. More than 250 APTA members came to Washington, D.C., with a shared message during APTA Capitol Hill Day: Physical therapy delivers high-value care and federal policy must keep pace to ensure sustainable access for

APTA Consumer Awareness Report Shows Deepening Knowledge of Physical Therapy

Sep 27, 2022/News

Based on a 2021 survey, the results show significant growth in the public's understanding of the profession's role and level of expertise.

The Proposed '24 Fee Schedule: Takeaways From APTA's Comments to CMS

Sep 8, 2023/News

APTA seized the opportunity to address the good, the bad, and the unclear.

New in PTJ: Exploring the Feasibility and Effectiveness of Telerehabilitation

Jun 25, 2024/News

Two recently published articles study adults with chronic low back pain and adults with autism spectrum disorder.

Coronavirus Update: July 7

Jul 7, 2021/Article

APTA COVID-19 Outcome Measures, "profound brain changes," updated return-to-sport guidance, and more.